Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant

Provided By PR Newswire

Last update: Dec 11, 2023

Funds will help advance MDS Education, Advocacy and Research

SAN DIEGO, Dec. 11, 2023 /PRNewswire/ -- Notable Labs, ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that it has donated $60,000 to the Myelodysplastic Syndrome Foundation, Inc. This donation was formally announced during the MDS Foundation 2023 Satellite Symposium at the 65th American Society of Hematology (ASH) Annual Meeting which Notable Labs also supported here in San Diego, Ca.